Metropolitan Life Insurance Company (MetLife)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,817
| Closed | -$5.8K | – | 2228 |
|
|
2024
Q1 | $5.8K | Sell |
1,817
-1,946
| -52% | -$6.21K | ﹤0.01% | 2238 |
|
|
2023
Q4 | $12.6K | Hold |
3,763
| – | – | ﹤0.01% | 2101 |
|
|
2023
Q3 | $8.96K | Hold |
3,763
| – | – | ﹤0.01% | 2257 |
|
|
2023
Q2 | $6.62K | Buy |
+3,763
| New | +$6.62K | ﹤0.01% | 2439 |
|
|
2021
Q2 | – | Sell |
-9,154
| Closed | -$87.4K | – | 2906 |
|
|
2021
Q1 | $87.4K | Buy |
+9,154
| New | +$87.4K | ﹤0.01% | 2459 |
|